This elevation of ASAH1 appears to confer radioresistance to GBM cells by decreasing the level of proapoptotic ceramide molecules, and increasing the level of prosurvival S1P molecules, and may contribute to recurrence (Table 2) [84]. This evidence concerns the gene ASAH1 and glioblastoma.